Cambodia becomes Asia's second nation to launch long-acting injectable PrEP for HIV prevention, marking strong progress toward ending AIDS.
Vous n'êtes pas connecté
Cambodia is now the second country in Asia, following Thailand, to initiate long-acting injectable medlinkpre-exposure prophylaxis (PrEP)/medlink to prevent HIV.
Cambodia becomes Asia's second nation to launch long-acting injectable PrEP for HIV prevention, marking strong progress toward ending AIDS.
Nairobi -- Kenya is set to roll out the long-acting injectable HIV Pre-Exposure prophylaxis (PrEP) Lenacapavir by January 2026 following its approval...
Nairobi -- Kenya is set to roll out the long-acting injectable HIV Pre-Exposure prophylaxis (PrEP) Lenacapavir by January 2026 following its approval...
The World Health Organisation (WHO) on Monday released a landmark policy, recommending the use of injectable Lenacapavir (LEN) twice a year as an...
In collaboration with the Gates Foundation, Merck advances MK-8527 pre-exposure prophylaxis (PrEP) clinical trials globally RAHWAY, N.J.--(BUSINESS...
GENEVA, Switzerland – The World Health Organization (WHO) released new guidelines recommending the use of injectable lenacapavir (LEN) twice a...
A BREAKTHROUGH HIV drug that only needs to be injected twice a year to offer near-total protection from the virus and developing AIDS should be made...
A BREAKTHROUGH HIV drug that only needs to be injected twice a year to offer near-total protection from the virus and developing AIDS should be made...
MSF welcomes the release of WHO guidelines for ‘game-changing’ HIV prevention drug, lenacapavir, but remains deeply concerned about access,...
MSF welcomes the release of WHO guidelines for ‘game-changing’ HIV prevention drug, lenacapavir, but remains deeply concerned about access,...